Antihypertensive effect and the underlying mechanisms of action of phytolaccagenin in rat models

Background Phytolaccagenin, a natural triterpenoid, is reported for various biological activities that indicate its potential role in the management of hypertension. Methods Phytolaccagenin was evaluated for its antihypertensive activity in rat models via in vivo and in vitro experiments using polye...

Full description

Bibliographic Details
Main Authors: Imran Ul Haq, Taseer Ahmad, Taous Khan, Abdul Jabbar Shah
Format: Article
Language:English
Published: Taylor & Francis Group 2022-08-01
Series:Clinical and Experimental Hypertension
Subjects:
Online Access:http://dx.doi.org/10.1080/10641963.2022.2079671
_version_ 1797681034605625344
author Imran Ul Haq
Taseer Ahmad
Taous Khan
Abdul Jabbar Shah
author_facet Imran Ul Haq
Taseer Ahmad
Taous Khan
Abdul Jabbar Shah
author_sort Imran Ul Haq
collection DOAJ
description Background Phytolaccagenin, a natural triterpenoid, is reported for various biological activities that indicate its potential role in the management of hypertension. Methods Phytolaccagenin was evaluated for its antihypertensive activity in rat models via in vivo and in vitro experiments using polyethylene tubings for cannulation, organ bath bubbled with carbogen gas, and a pressure transducer connected to a PowerLab data acquisition system. Results Intravenous administration of phytolaccagenin decreased mean arterial pressure (MAP), significantly, in normotensive and hypertensive anesthetized rats. Pretreatment of rats with atropine (2 mg/kg) partially reversed the decrease in blood pressure due to phytolaccagenin at first tested doses. However, Nω-nitro-L-arginine methyl ester (L-NAME) (100 mg/kg) pretreatment modified the effect of phytolaccagenin on blood pressure with greater response. In isolated rat aortic rings precontracted with phenylephrine, cumulative addition of phytolaccagenin induced relaxation that is ablated (50%) with denudation and pre-incubation with atropine (1 μM) and L-NAME (10 μM). Phytolaccagenin also partially inhibited high K+ precontraction at initial doses, while an inhibitory effect was observed at higher concentrations, confirming its effect on voltage-dependent calcium channels. In isolated spontaneously beating rat atrial strips, phytolaccagenin suppressed the atrial tone that was reduced with isoprenaline and atropine pre-incubation, suggesting the role of cardiac adrenergic and muscarinic receptors. Interestingly, atenolol (1 μM) pretreatment also ablated the cardiac effects of phytolaccagenin. Conclusion The antihypertensive effect of phytolaccagenin is due to a decrease in vascular resistance and cardiac depressant effects. These effects are mediated via muscarinic receptors-linked NO pathway, inhibitory effect on Ca2+ movements (vascular), and activation of cardiac muscarinic and blockade of β-adrenergic receptors.
first_indexed 2024-03-11T23:39:02Z
format Article
id doaj.art-8f7c2a07a8fc473183582c11e5d31f94
institution Directory Open Access Journal
issn 1064-1963
1525-6006
language English
last_indexed 2024-03-11T23:39:02Z
publishDate 2022-08-01
publisher Taylor & Francis Group
record_format Article
series Clinical and Experimental Hypertension
spelling doaj.art-8f7c2a07a8fc473183582c11e5d31f942023-09-19T16:04:08ZengTaylor & Francis GroupClinical and Experimental Hypertension1064-19631525-60062022-08-0144655756610.1080/10641963.2022.20796712079671Antihypertensive effect and the underlying mechanisms of action of phytolaccagenin in rat modelsImran Ul Haq0Taseer Ahmad1Taous Khan2Abdul Jabbar Shah3COMSATS University IslamabadCollege of Pharmacy, University of Sargodha, University RoadCOMSATS University IslamabadCOMSATS University IslamabadBackground Phytolaccagenin, a natural triterpenoid, is reported for various biological activities that indicate its potential role in the management of hypertension. Methods Phytolaccagenin was evaluated for its antihypertensive activity in rat models via in vivo and in vitro experiments using polyethylene tubings for cannulation, organ bath bubbled with carbogen gas, and a pressure transducer connected to a PowerLab data acquisition system. Results Intravenous administration of phytolaccagenin decreased mean arterial pressure (MAP), significantly, in normotensive and hypertensive anesthetized rats. Pretreatment of rats with atropine (2 mg/kg) partially reversed the decrease in blood pressure due to phytolaccagenin at first tested doses. However, Nω-nitro-L-arginine methyl ester (L-NAME) (100 mg/kg) pretreatment modified the effect of phytolaccagenin on blood pressure with greater response. In isolated rat aortic rings precontracted with phenylephrine, cumulative addition of phytolaccagenin induced relaxation that is ablated (50%) with denudation and pre-incubation with atropine (1 μM) and L-NAME (10 μM). Phytolaccagenin also partially inhibited high K+ precontraction at initial doses, while an inhibitory effect was observed at higher concentrations, confirming its effect on voltage-dependent calcium channels. In isolated spontaneously beating rat atrial strips, phytolaccagenin suppressed the atrial tone that was reduced with isoprenaline and atropine pre-incubation, suggesting the role of cardiac adrenergic and muscarinic receptors. Interestingly, atenolol (1 μM) pretreatment also ablated the cardiac effects of phytolaccagenin. Conclusion The antihypertensive effect of phytolaccagenin is due to a decrease in vascular resistance and cardiac depressant effects. These effects are mediated via muscarinic receptors-linked NO pathway, inhibitory effect on Ca2+ movements (vascular), and activation of cardiac muscarinic and blockade of β-adrenergic receptors.http://dx.doi.org/10.1080/10641963.2022.2079671phytolaccageninantihypertensivecalcium movementnitric oxidemuscarinicβ- receptors
spellingShingle Imran Ul Haq
Taseer Ahmad
Taous Khan
Abdul Jabbar Shah
Antihypertensive effect and the underlying mechanisms of action of phytolaccagenin in rat models
Clinical and Experimental Hypertension
phytolaccagenin
antihypertensive
calcium movement
nitric oxide
muscarinic
β- receptors
title Antihypertensive effect and the underlying mechanisms of action of phytolaccagenin in rat models
title_full Antihypertensive effect and the underlying mechanisms of action of phytolaccagenin in rat models
title_fullStr Antihypertensive effect and the underlying mechanisms of action of phytolaccagenin in rat models
title_full_unstemmed Antihypertensive effect and the underlying mechanisms of action of phytolaccagenin in rat models
title_short Antihypertensive effect and the underlying mechanisms of action of phytolaccagenin in rat models
title_sort antihypertensive effect and the underlying mechanisms of action of phytolaccagenin in rat models
topic phytolaccagenin
antihypertensive
calcium movement
nitric oxide
muscarinic
β- receptors
url http://dx.doi.org/10.1080/10641963.2022.2079671
work_keys_str_mv AT imranulhaq antihypertensiveeffectandtheunderlyingmechanismsofactionofphytolaccagenininratmodels
AT taseerahmad antihypertensiveeffectandtheunderlyingmechanismsofactionofphytolaccagenininratmodels
AT taouskhan antihypertensiveeffectandtheunderlyingmechanismsofactionofphytolaccagenininratmodels
AT abduljabbarshah antihypertensiveeffectandtheunderlyingmechanismsofactionofphytolaccagenininratmodels